Amonsot, Maria L.
HRN: 28-71-30 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/20/2026
03/27/2026
IV
600mg
Q6H
Cellulitis
Checking Initial Appropriateness
03/20/2026
CIPROFLOXACIN 500MG (TAB)
03/20/2026
03/27/2026
PO
500
BID
Cellulitis
Checking Initial Appropriateness
03/23/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/23/2026
03/30/2026
IVTT
1.5g
Q6H
CELLULITIS
Checking Initial Appropriateness
03/28/2026
CLINDAMYCIN 300MG (CAP)
03/28/2026
04/03/2026
PO
300mg
Q8
Cellulits
Checking Initial Appropriateness